Appointment of Consultant to manage Singapore R&D Facility
Filed with ASX · · 2 pages · English
Earlier from BPH Global
- Market Update
- Reinstatement to Official Quotation - 30 March 2023
- SCU secures firm commitments to raise $1m
- Proposed Capital Raising, Board Changes and Company Update
- Adjustments to the 4E Unaudited Financial Statements
Later from BPH Global
- Market Update on China business activities
- 30 Days Market Update on China business activities
- Joint venture with Singapore-based Chemokine Yuesheng
- BP8 to acquire China-based Foshan Gedishi Biotechnology Co
- BPH Global receives funding commitments of A$800,000
Follow BPH Global into a list and get an email when it puts out news.
Follow BPH Global